These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29055857)

  • 1. Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking.
    Batran RZ; Dawood DH; El-Seginy SA; Maher TJ; Gugnani KS; Rondon-Ortiz AN
    Bioorg Chem; 2017 Dec; 75():274-290. PubMed ID: 29055857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New quinolone derivatives as neuropeptide S receptor antagonists: Design, synthesis, homology modeling, dynamic simulations and modulation of Gq/Gs signaling pathways.
    Batran RZ; Gugnani KS; Maher TJ; Khedr MA
    Bioorg Chem; 2021 Jun; 111():104817. PubMed ID: 33848721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-Activity Relationship Studies on Oxazolo[3,4-
    Albanese V; Ruzza C; Marzola E; Bernardi T; Fabbri M; Fantinati A; Trapella C; Reinscheid RK; Ferrari F; Sturaro C; Calò G; Amendola G; Cosconati S; Pacifico S; Guerrini R; Preti D
    J Med Chem; 2021 Apr; 64(7):4089-4108. PubMed ID: 33733768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide S receptor ligands: a patent review (2005-2016).
    Ruzza C; Calò G; Di Maro S; Pacifico S; Trapella C; Salvadori S; Preti D; Guerrini R
    Expert Opin Ther Pat; 2017 Mar; 27(3):347-362. PubMed ID: 27788040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide S receptor: recent updates on nonpeptide antagonist discovery.
    Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
    ChemMedChem; 2011 Jul; 6(7):1163-71. PubMed ID: 21452188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Pharmacophoric Approach in the Design and Synthesis of Coumarin Linked Pyrazolinyl as Urease Inhibitors, Kinetic Mechanism and Molecular Docking.
    Saeed A; Mahesar PA; Channar PA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
    Chem Biodivers; 2017 Aug; 14(8):. PubMed ID: 28574649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling studies on the human neuropeptide S receptor and its antagonists.
    Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Vittori S; Volpini R; Cristalli G
    ChemMedChem; 2010 Mar; 5(3):371-83. PubMed ID: 20087922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.
    Hui WQ; Cheng Q; Liu TY; Ouyang Q
    J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
    Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
    Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [tBu-D-Gly5]NPS, a pure and potent antagonist of the neuropeptide S receptor: in vitro and in vivo studies.
    Ruzza C; Rizzi A; Camarda V; Pulga A; Marzola G; Filaferro M; Novi C; Ruggieri V; Marzola E; Vitale G; Salvadori S; Guerrini R; Calo' G
    Peptides; 2012 Apr; 34(2):404-11. PubMed ID: 22342393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat.
    Cifani C; Micioni Di Bonaventura MV; Cannella N; Fedeli A; Guerrini R; Calo G; Ciccocioppo R; Ubaldi M
    Peptides; 2011 Jan; 32(1):44-50. PubMed ID: 20971145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure guided design of potential inhibitors of human calcium-calmodulin dependent protein kinase IV containing pyrimidine scaffold.
    Naz H; Jameel E; Hoda N; Shandilya A; Khan P; Islam A; Ahmad F; Jayaram B; Hassan MI
    Bioorg Med Chem Lett; 2016 Feb; 26(3):782-788. PubMed ID: 26783179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor.
    Guerrini R; Salvadori S; Rizzi A; Regoli D; Calo' G
    Med Res Rev; 2010 Sep; 30(5):751-77. PubMed ID: 19824051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.
    Camarda V; Rizzi A; Ruzza C; Zucchini S; Marzola G; Marzola E; Guerrini R; Salvadori S; Reinscheid RK; Regoli D; Calò G
    J Pharmacol Exp Ther; 2009 Feb; 328(2):549-55. PubMed ID: 18971372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico characterization of ligand binding modes in the human histamine H4 receptor and their impact on receptor activation.
    Werner T; Sander K; Tanrikulu Y; Kottke T; Proschak E; Stark H; Schneider G
    Chembiochem; 2010 Sep; 11(13):1850-5. PubMed ID: 20665769
    [No Abstract]   [Full Text] [Related]  

  • 16. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
    Patny A; Desai PV; Avery MA
    Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis.
    Ibrar A; Zaib S; Jabeen F; Iqbal J; Saeed A
    Arch Pharm (Weinheim); 2016 Jul; 349(7):553-65. PubMed ID: 27214743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.
    Guerrini R; Camarda V; Trapella C; Caló G; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    J Med Chem; 2009 Jul; 52(13):4068-71. PubMed ID: 19473027
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.